X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (94) 94
oncology (77) 77
index medicus (66) 66
female (50) 50
mesothelioma (44) 44
mesothelin (41) 41
article (40) 40
male (38) 38
animals (36) 36
cancer (35) 35
immunotherapy (31) 31
middle aged (31) 31
aged (29) 29
mice (29) 29
gpi-linked proteins (28) 28
cell line, tumor (24) 24
adult (22) 22
expression (21) 21
mesothelioma - pathology (21) 21
tumors (21) 21
diagnosis (20) 20
antibodies, monoclonal - therapeutic use (18) 18
antitumor-activity (18) 18
immunohistochemistry (18) 18
malignant pleural mesothelioma (18) 18
mesothelioma - drug therapy (18) 18
recombinant immunotoxin (17) 17
care and treatment (16) 16
chemotherapy (16) 16
ovarian-cancer (16) 16
peptides (16) 16
chemistry (15) 15
malignant mesothelioma (15) 15
metallurgy (15) 15
mice, nude (15) 15
organic chemistry (15) 15
endocrine system diseases (14) 14
membrane glycoproteins - immunology (14) 14
gpi-linked proteins - metabolism (13) 13
immunotoxin (13) 13
mesothelioma - immunology (13) 13
monoclonal-antibody (13) 13
research (13) 13
ss1p (13) 13
adenocarcinomas (12) 12
antibodies, monoclonal - administration & dosage (12) 12
antibodies, monoclonal - immunology (12) 12
cells (12) 12
mesothelioma - therapy (12) 12
molecular-cloning (12) 12
mutation (12) 12
neoplasms - drug therapy (12) 12
ovarian cancer (12) 12
pancreatic cancer (12) 12
peritoneal mesothelioma (12) 12
proteins (12) 12
xenograft model antitumor assays (12) 12
human necessities (11) 11
hygiene (11) 11
immunotoxins - therapeutic use (11) 11
medical or veterinary science (11) 11
mesothelioma - genetics (11) 11
neoplasms - immunology (11) 11
phase-i trial (11) 11
preparations for medical, dental, or toilet purposes (11) 11
aged, 80 and over (10) 10
antibodies, monoclonal - pharmacology (10) 10
apoptosis (10) 10
mesothelioma - diagnosis (10) 10
mesothelioma - metabolism (10) 10
ovarian cancers (10) 10
phase-i (10) 10
pleural mesothelioma (10) 10
prognosis (10) 10
respiratory system (10) 10
therapy (10) 10
antigens (9) 9
gpi-linked proteins - immunology (9) 9
health aspects (9) 9
in-vitro (9) 9
lung neoplasms - pathology (9) 9
membrane glycoproteins - metabolism (9) 9
monoclonal antibody (9) 9
tumor cells, cultured (9) 9
antibodies, monoclonal - pharmacokinetics (8) 8
antineoplastic combined chemotherapy protocols - therapeutic use (8) 8
carcinoma (8) 8
hematology, oncology and palliative medicine (8) 8
identification (8) 8
immunotherapy - methods (8) 8
immunotoxins - immunology (8) 8
investigating or analysing materials by determining theirchemical or physical properties (8) 8
lung neoplasms - genetics (8) 8
measuring (8) 8
mesothelioma - mortality (8) 8
multidisciplinary sciences (8) 8
neoplasm staging (8) 8
physics (8) 8
pleural neoplasms - pathology (8) 8
pseudomonas exotoxin (8) 8
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Lancet Oncology, ISSN 1470-2045, 02/2020, Volume 21, Issue 2, pp. e117 - e117
Journal Article
The Lancet Oncology, ISSN 1470-2045, 09/2017, Volume 18, Issue 9, pp. 1150 - 1151
Journal Article
Journal Article
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 3/2009, Volume 106, Issue 9, pp. 3360 - 3365
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 7/2012, Volume 109, Issue 29, pp. 11782 - 11787
Journal Article
Oncotarget, ISSN 1949-2553, 11/2018, Volume 9, Issue 90, p. 36050
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 6/2014, Volume 111, Issue 23, pp. 8571 - 8576
Nonhuman proteins have valuable therapeutic properties, but their efficacy is limited by neutralizing antibodies. Recombinant immunotoxins (RITs) are potent... 
T lymphocytes | Immunotoxins | Hairy cell leukemia | Immune response | Cell lines | Antibodies | T lymphocyte epitopes | B lymphocyte epitopes | Epitopes | Tumors | Protein engineering | Deimmunization | IMMUNODOMINANCE | ANTIGENICITY | MOXETUMOMAB PASUDOTOX | DETERMINANTS | PROTEIN THERAPEUTICS | MULTIDISCIPLINARY SCIENCES | ELIMINATION | deimmunization | TOXICITY | protein engineering | PHASE-I TRIAL | PSEUDOMONAS-AERUGINOSA | EXOTOXIN-A | Recombinant Fusion Proteins - immunology | Epitope Mapping | Immunotherapy - methods | Virulence Factors - genetics | Humans | Recombinant Fusion Proteins - therapeutic use | Amino Acids - immunology | Peptides - genetics | Virulence Factors - immunology | Amino Acids - genetics | Lymphocyte Activation - immunology | Neoplasms - therapy | T-Lymphocytes - metabolism | T-Lymphocytes - drug effects | Bacterial Toxins - genetics | Female | Epitopes, T-Lymphocyte - immunology | Protein Structure, Tertiary | ADP Ribose Transferases - immunology | Cell Survival - drug effects | Antibody Formation - immunology | Immunotoxins - immunology | Bacterial Toxins - immunology | Electrophoresis, Polyacrylamide Gel | Exotoxins - immunology | Peptides - immunology | Models, Molecular | Recombinant Fusion Proteins - chemistry | Cell Survival - immunology | Mice, SCID | Xenograft Model Antitumor Assays | ADP Ribose Transferases - genetics | Point Mutation | Immunotoxins - genetics | Animals | Immunotoxins - therapeutic use | Lymphocyte Activation - drug effects | Neoplasms - immunology | Exotoxins - genetics | Cell Line, Tumor | T-Lymphocytes - immunology | Mice | Neoplasms - pathology | Care and treatment | Oncology, Experimental | Research | T cells | Recombinant proteins | Health aspects | Cancer | Biological Sciences
Journal Article